Back

Distinct Global Patterns and Trends in Lifetime Risk of Rectal Cancer Within Colorectal Cancer: A Population-Based Analysis from GLOBOCAN 2022

Pang, K.; An, X.; Song, K.; Xie, F.; Ding, H.; Zhou, H.; He, Z.; Chen, H.; Wu, D.

2026-03-31 public and global health
10.64898/2026.03.30.26349699 medRxiv
Show abstract

Background: Rectal cancer (RC) is traditionally grouped within colorectal cancer (CRC), despite growing evidence of distinct epidemiologic features. However, global comparative assessments of lifetime risks of RC relative to CRC remain limited. We aimed to estimate lifetime risks of developing and dying from RC and CRC worldwide and to examine geographic, socioeconomic, and temporal variations in the proportional contribution of RC within CRC. Methods: Age-specific incidence and mortality estimates for RC and CRC across 185 countries were obtained from GLOBOCAN 2022, together with population and all-cause mortality data from the United Nations. Lifetime risks of incidence (LRI) and mortality (LRM) were calculated using the adjusted-for-multiple-primaries (AMP) method by sex, country, region, and Human Development Index (HDI). The RC-to-CRC lifetime risk ratio quantified the proportional contribution of RC. Temporal trends were assessed in 42 countries using Cancer Incidence in Five Continents Plus (CI5plus) data and average annual percent change (AAPC). Results: In 2022, the global lifetime risk of developing RC was 1.61% and dying from RC was 0.95%, accounting for approximately 35% of the corresponding CRC lifetime burden (4.61% and 2.68%). Absolute lifetime risks of both RC and CRC increased with HDI. In contrast, the proportional contribution of RC varied markedly, peaking at 41%-43% in Central and South-Eastern Asia but falling below 20% in the Caribbean and Central America, and showed a negative association with HDI. The LRI/LRM ratio increased with socioeconomic development. Temporal analyses showed increasing LRI trends in 17 of 42 countries for CRC versus 9 for RC, while declines occurred in 14 countries for RC and 11 for CRC. Conclusions: RC constitutes a substantial yet epidemiologically distinct component of the global CRC burden. Its proportional contribution varies across regions and does not parallel absolute risk patterns, supporting the need for subsite-specific surveillance and prevention strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
International Journal of Cancer
42 papers in training set
Top 0.1%
23.0%
2
BMC Cancer
52 papers in training set
Top 0.1%
14.7%
3
Cancer Medicine
24 papers in training set
Top 0.1%
7.0%
4
PLOS ONE
4510 papers in training set
Top 24%
7.0%
50% of probability mass above
5
Scientific Reports
3102 papers in training set
Top 22%
5.0%
6
BMC Medicine
163 papers in training set
Top 0.9%
4.4%
7
International Journal of Epidemiology
74 papers in training set
Top 0.7%
3.3%
8
BMC Public Health
147 papers in training set
Top 2%
3.1%
9
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
2.9%
10
Cancers
200 papers in training set
Top 3%
1.8%
11
British Journal of Cancer
42 papers in training set
Top 0.7%
1.8%
12
Frontiers in Oncology
95 papers in training set
Top 2%
1.7%
13
Nature Communications
4913 papers in training set
Top 50%
1.7%
14
Annals of Internal Medicine
27 papers in training set
Top 0.6%
1.3%
15
Nature Medicine
117 papers in training set
Top 3%
1.1%
16
eLife
5422 papers in training set
Top 53%
0.9%
17
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.5%
0.9%
18
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
19
EClinicalMedicine
21 papers in training set
Top 0.9%
0.8%
20
eBioMedicine
130 papers in training set
Top 4%
0.8%
21
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
22
Cancer Letters
32 papers in training set
Top 0.8%
0.7%
23
Eurosurveillance
80 papers in training set
Top 2%
0.7%
24
The Lancet Digital Health
25 papers in training set
Top 1%
0.7%
25
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.7%
26
PLOS Medicine
98 papers in training set
Top 6%
0.5%
27
Epidemiology and Infection
84 papers in training set
Top 4%
0.5%
28
Diagnostics
48 papers in training set
Top 3%
0.5%